OmniAb (OABI) Non Operating Income (2023 - 2026)
OmniAb (OABI) reported Non Operating Income of $564000.0 for Q1 2026, up 4.83% year-over-year from $538000.0 in Q1 2025, and up 139.17% quarter-over-quarter from -$1.4 million in Q4 2025.
OmniAb (OABI) Non Operating Income (2023 - 2026) Analysis & Trends
OmniAb (OABI) has 4 years of Non Operating Income data on file, last reported at $564000.0 in Q1 2026.
- Non Operating Income for Q1 2026 came in at $564000.0, up 4.83% year-over-year; the trailing twelve-month figure through Mar 2026 was -$857000.0 (down 170.59% YoY), and the FY2025 annual result was $15000.0, up 200.0% from the prior year.
- Non Operating Income improved to $564000.0 in Q1 2026 per OABI's latest filing, from -$1.4 million in the prior quarter.
- Over five years, Non Operating Income peaked at $1.3 million in Q1 2023 and troughed at -$3.9 million in Q4 2023.
- A 4-year average of -$93615.4 and a median of $8000.0 in 2023 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2024 and 2025: Non Operating Income soared 8437.5% in 2024, then slumped 72100.0% in 2025.
- A 4-year view of Non Operating Income shows it stood at -$3.9 million in 2023, then soared by 100.05% to $2000.0 in 2024, then tumbled by 72100.0% to -$1.4 million in 2025, then soared by 139.17% to $564000.0 in 2026.
- Business Quant data shows OABI's Non Operating Income at $564000.0 in Q1 2026, -$1.4 million in Q4 2025, and -$8000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | OmniAb | 294.96 Mn | 252.00 Mn | 14.41 Mn | 564,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 564,000.00 |
| Dec 31, 2025 | -1.44 Mn |
| Sep 30, 2025 | -8,000.00 |
| Jun 30, 2025 | 27,000.00 |
| Mar 31, 2025 | 538,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | 683,000.00 |
| Jun 30, 2024 | -9,000.00 |
| Mar 31, 2024 | 975,000.00 |
| Dec 31, 2023 | -3.88 Mn |
| Sep 30, 2023 | 8,000.00 |
| Jun 30, 2023 | -4,000.00 |
| Mar 31, 2023 | 1.32 Mn |